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The title compound, C15H10FNO3, was prepared from 2-
nitroacetphenone and 4-ﬂuorobenzaldehyde by an Aldol
condensation reaction. The dihedral angle formed by the
two benzene rings is 67.37 (2) . The crystal structure is
stabilized by weak intermolecular C—H   O and C—H   F
hydrogen bonds.
Related literature
For the biological activities of chalcones, see: Hsieh et al.
(1998); Anto et al. (1994); De Vincenzo et al.(2000); Dimmock







a = 7.7698 (16) A ˚
b = 17.072 (3) A ˚
c = 9.759 (2) A ˚
  = 96.72 (3) 
V = 1285.6 (5) A ˚ 3
Z =4
Mo K  radiation
  = 0.11 mm
 1
T = 293 K


















 max = 0.24 e A ˚  3
 min =  0.19 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
C4—H4A   O3
i 0.93 2.57 3.500 (2) 177
C5—H5A   F1
ii 0.93 2.54 3.396 (2) 153
C9—H9A   O3
iii 0.93 2.57 3.411 (2) 150
Symmetry codes: (i) x þ 1;y;z; (ii)  x þ 1; y; z þ 2; (iii)  x; y; z þ 1.
Data collection: SMART (Bruker, 1997); cell reﬁnement: SAINT
(Bruker, 1997); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
SHELXTL (Sheldrick, 2008); software used to prepare material for
publication: SHELXTL.
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